Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Michael Batey

Newcastle AuthorsTitleYearFull text
Dr Britta Vormoor
Henrike Knizia
Michael Batey
Dr Ian Wilson
Dr Petra Dildey
et al.		Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging2014
Michael Batey
Dr Frida Ponthan
Dr Helen Blair
Professor Olaf Heidenreich
The development and evaluation of a series of novel in vivo imaging models of AML for the assessment of drug efficacy2014
Michael Batey
Dr Yan Zhao
Suzanne Kyle
Emeritus Professor Herbie Newell
Professor Nicola Curtin
Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer2013
Michael Batey
Dr Frida Ponthan
Professor Olaf Heidenreich
The use of a novel in vivo orthotopic imaging model of AML for assessment of drug efficacy2013
Dr Joanne Martin
Michael Batey
Dr Yan Zhao
Dr Celine Cano
Dr Michele Tavecchio
et al.		Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K2012
Michael Batey
Dr Yan Zhao
Dr Helen Maitland
Professor Hing Leung
Emeritus Professor Andy Hall
et al.		Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma2011
Michael Batey
Professor Julie Irving
Emeritus Professor Herbie Newell
Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models2011
Patricia Garrido Castro
Dr Simon Bomken
Elda Latif
Michael Batey
Hesta McNeill
et al.		ANGIOPOIETIN1 a Novel Factor Implicated In MLL Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene Dependent Manner2010
Elda Latif
Michael Batey
Hesta McNeill
Professor Josef Vormoor
Professor Olaf Heidenreich
ANGIOPOIETIN1-a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner2010
Henrike Knizia
Michael Batey
Gilberto de Almeida
Dr Ross Maxwell
Dr Petra Dildey
et al.		Development of an orthotopic model for human malignant bone diseases in immunocompromised NOD.Cg-PrkdcscidIl2rgtmlwjl/szj (NSG) mice2010
Michael Batey
Emeritus Professor Herbie Newell
Professor Nicola Curtin
Chemosensitisation of cancer cells by KU-0060648, a potent and selective inhibitor of DNA-PK [abstract]2008
Michael Batey
Dr Amy Peasland
Professor Julie Irving
Emeritus Professor Herbie Newell
Development of inhibitors of the fibroblast growth factor receptor (FGFR) kinase using a fragment based approach2008
Michael Batey
Dr Helen Maitland
Professor Hing Leung
Emeritus Professor Andy Hall
Professor Graham Jackson
et al.		In vitro activity of the multi targeted receptor tyrosine kinase inhibitor sunitinib against multiple myeloma cell lines is not predictive of in vivo xenograft response2008
Michael Batey
Dr Laurent Rigoreau
Professor Roger Griffin
Emeritus Professor Herbie Newell
Professor Nicola Curtin
Potent in vitro and in vivo radiosensitisation by the selective DNA-dependent protein kinase inhibitor KU-0060648 [abstract]2008
Dr Patricia Turner
Mike Cole
Michael Batey
Sandra Beare
Professor Alan Boddy
Reduced folate carrier single nucleotide polymorphism associated with methotrexate clearance in breast cancer patients2008
12